Cargando…
157 Pathogenesis of Epstein-Barr Virus-driven lymphomas of HIV+ patients: new insights of potential clinical relevance
Human Immunodeficiency Virus (HIV)+ patients have an increased risk to develop lymphomas, including a significant fraction of histotypes associated with Epstein-Barr Virus (EBV) infection. Although restoration of EBV-specific T-cell function induced by HAART has led to a decreased incidence of the m...
Autor principal: | Dolcetti, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149620/ http://dx.doi.org/10.1097/01.qai.0000446741.08719.ff |
Ejemplares similares
-
Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders
por: Martorelli, Debora, et al.
Publicado: (2012) -
Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor?
por: Dolcetti, Riccardo, et al.
Publicado: (2010) -
Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma
por: Ross, Aisling M., et al.
Publicado: (2023) -
Epstein–Barr Virus History and Pathogenesis
por: Yu, Hui, et al.
Publicado: (2023) -
Epstein-Barr virus and telomerase: from cell immortalization to therapy
por: Dolcetti, Riccardo, et al.
Publicado: (2014)